PHOTOAFFINITY-LABELING OF TORPEDO ACETYLCHOLINE-RECEPTOR BY PHYSOSTIGMINE

被引:69
作者
SCHRATTENHOLZ, A
GODOVAC-ZIMMERMANN, J
SCHAFER, HJ
ALBUQUERQUE, EX
MAELICKE, A
机构
[1] UNIV MAINZ, SCH MED, INST PHYSIOL CHEM & PATHOBIOCHEM, DUESBERGWEG 6, W-6500 MAINZ, GERMANY
[2] UNIV MAINZ, INST BIOCHEM, W-6500 MAINZ, GERMANY
[3] UNIV MARYLAND, SCH MED, DEPT PHARMACOL, BALTIMORE, MD 21201 USA
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 1993年 / 216卷 / 02期
关键词
D O I
10.1111/j.1432-1033.1993.tb18187.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The plant alkaloid physostigmine, an established anti-cholinesterase agent of t he carbamate type, has recently been shown to bind to the nicotinic acetylcholine receptor from Torpedo marmorata electrocytes [Okonjo, K. O., Kuhlmann, J. & Maelicke, A. (1991) Eur J. Biochem. 200,671-677]. Pharmacological studies of physostigmine-induced ion flux into nicotinic-acetylcholine-receptor-rich membrane vesicles, indicated distinct binding sites for physostigmine and acetylcholine. As shown in this study by photoaffinity labeling with [phenyl-(n)-H-3](-)physostigmine, the physostigmine-binding site is located within the same subunit (alpha polypeptide) of the receptor as the acetylcholine-binding site. Using a variety of proteolytic cleavage conditions for the purified alpha polypeptide, several, [H-3]physostigmine-labeled peptides were isolated and sequenced. From the radioactivity released in the course of the Edman degradations of the labeled peptides, it was found that the label was associated in all cases with Lys125. These results identify a novel ligand-binding site for the Torpedo nicotinic acetylcholine receptor that is different in location from binding sites identified previously for acetylcholine, its established agonists and antagonists, and direct channel blockers.
引用
收藏
页码:671 / 677
页数:7
相关论文
共 50 条
[1]  
ABRAMSON SN, 1989, J BIOL CHEM, V264, P12666
[2]   EFFECTS OF MORPHINE, PHYSOSTIGMINE AND RAPHE NUCLEI STIMULATION ON 5-HYDROXYTRYPTAMINE RELEASE FROM THE CEREBRAL-CORTEX OF THE CAT [J].
AIELLOMALMBERG, P ;
BARTOLINI, A ;
BARTOLINI, R ;
GALLI, A .
BRITISH JOURNAL OF PHARMACOLOGY, 1979, 65 (04) :547-555
[3]  
ALBUQUERQUE EX, 1989, INSECTICIDE ACTION, P33
[4]  
ALBUQUERQUE EX, 1989, NEUROMUSCULAR JUNCTI, P273
[5]   THE MOLECULAR-BASIS OF ANTICHOLINESTERASE ACTIONS ON NICOTINIC AND GLUTAMATERGIC SYNAPSES [J].
ARACAVA, Y ;
DESHPANDE, SS ;
RICKETT, DL ;
BROSSI, A ;
SCHONENBERGER, B ;
ALBUQUERQUE, EX .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 505 :226-255
[6]  
BHAT RV, 1990, J PHARMACOL EXP THER, V255, P187
[7]   AGONIST AND INHIBITORY EFFECTS OF PYRIDOSTIGMINE AT THE NEUROMUSCULAR-JUNCTION [J].
BRADLEY, RJ ;
STERZ, R ;
PEPER, K .
BRAIN RESEARCH, 1986, 376 (01) :199-203
[8]  
CARPENTER DO, 1976, MOL PHARMACOL, V12, P999
[9]   THE TIPS LECTURE - THE NICOTINIC ACETYLCHOLINE-RECEPTOR - AN ALLOSTERIC PROTEIN PROTOTYPE OF LIGAND-GATED ION CHANNELS [J].
CHANGEUX, JP .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (12) :485-492
[10]   MAPPING OF A CHOLINERGIC BINDING-SITE BY MEANS OF SYNTHETIC PEPTIDES, MONOCLONAL-ANTIBODIES, AND ALPHA-BUNGAROTOXIN [J].
CONTITRONCONI, BM ;
TANG, F ;
DIETHELM, BM ;
SPENCER, SR ;
REINHARDTMAELICKE, S ;
MAELICKE, A .
BIOCHEMISTRY, 1990, 29 (26) :6221-6230